Second Sight Reports Fourth Quarter and Year End 2016 Financial Results

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three- and twelve-month periods ended December 31, 2016. Full Year 2016 and Recent Company Highlights: Completed an oversubscribed Rights Offering in March 2017 for existing shareholders and raised $20.1 million in gro

Full Story →